| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1012562820 |
| P356 | DOI | 10.1038/323816A0 |
| P698 | PubMed publication ID | 3022155 |
| P2093 | author name string | H Kirchner | |
| H Jacobsen | |||
| J Mestan | |||
| S Mittnacht | |||
| W Digel | |||
| D Blohm | |||
| A Möller | |||
| H Hillen | |||
| P2860 | cites work | An endotoxin-induced serum factor that causes necrosis of tumors | Q24564406 |
| Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 | Q25938983 | ||
| A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding | Q25938984 | ||
| Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin | Q28306447 | ||
| Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxin | Q34258651 | ||
| Tumor necrosis factor (TNF). | Q34378376 | ||
| Fibroblast growth enhancing activity of tumor necrosis factor and its relationship to other polypeptide growth factors | Q36351673 | ||
| Interferon Appearance Stimulated by Endotoxin, Bacteria, or Viruses in Mice Pre-Treated with Escherichia coli Endotoxin or Infected with Mycobacterium tuberculosis | Q47718724 | ||
| Induction of beta 2-interferon by tumor necrosis factor: a homeostatic mechanism in the control of cell proliferation. | Q54779287 | ||
| Effect of tumour necrosis factor on cultured human melanoma cells | Q67358604 | ||
| The interferon-induced enzyme oligo-isoadenylate synthetase: Rapid determination of its in vitro products | Q72630815 | ||
| P433 | issue | 6091 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | TNF | Q18032037 |
| P304 | page(s) | 816-819 | |
| P577 | publication date | 1986-10-01 | |
| P1433 | published in | Nature | Q180445 |
| P1476 | title | Antiviral effects of recombinant tumour necrosis factor in vitro | |
| P478 | volume | 323 |
| Q42497551 | 2'-5' oligoadenylate synthetase and its relationship to HLA and genetic markers of insulin-dependent diabetes mellitus |
| Q41436437 | A 14,700 MW protein from the E3 region of adenovirus inhibits cytolysis by tumor necrosis factor |
| Q44141073 | A diffusible lymphokine produced by CD8+ T lymphocytes suppresses HIV replication. |
| Q36802357 | A protein serologically and functionally related to the group C E3 14,700-kilodalton protein is found in multiple adenovirus serotypes |
| Q43968613 | A sensitive biological assay for interferons |
| Q45755984 | Acceleration of virus-induced apoptosis by tumor necrosis factor |
| Q36689099 | Adenovirus E3 14.7K protein functions in the absence of other adenovirus proteins to protect transfected cells from tumor necrosis factor cytolysis |
| Q39877642 | Altered susceptibility to tumor necrosis factor alpha-induced apoptosis of mouse cells expressing polyomavirus middle and small T antigens. |
| Q41189435 | Alveolar macrophages from patients with AIDS and AIDS-related complex constitutively synthesize and release tumor necrosis factor alpha |
| Q33923680 | Anti-Fas monoclonal antibody is cytocidal to human immunodeficiency virus-infected cells without augmenting viral replication |
| Q35858429 | Anti-human cytomegalovirus activity of cytokines produced by CD4+ T-cell clones specifically activated by IE1 peptides in vitro. |
| Q33937471 | Antigen-specific regulation of T cell-mediated cytokine production |
| Q73581110 | Antioxidants inhibit TNFalpha-induced motility and invasion of human osteosarcoma cells: possible involvement of NFkappaB activation |
| Q36380797 | Antiviral activity of tumor necrosis factor (TNF) is mediated via p55 and p75 TNF receptors |
| Q40646905 | Beta interferon subtype 1 induction by tumor necrosis factor |
| Q27486090 | Blockade of virus infection by human CD4+ T cells via a cytokine relay network |
| Q39527191 | Cachectin/tumor necrosis factor exerts endocrine, paracrine, and autocrine control of inflammatory responses |
| Q38347360 | Cachectin/tumour necrosis factor |
| Q39555654 | Cachetin/TNF: a macrophage protein that induces cachexia and shock |
| Q36686459 | Characterization of mutants within the gene for the adenovirus E3 14.7-kilodalton protein which prevents cytolysis by tumor necrosis factor. |
| Q72712099 | Circulating proinflammatory cytokines (IL-1 beta, TNF-alpha, and IL-6) and IL-1 receptor antagonist (IL-1Ra) in fulminant hepatic failure and acute hepatitis |
| Q73571738 | Constitutive and induced cytokine production by human placenta and amniotic membrane at term |
| Q36009894 | Convergent Transcription of Interferon-stimulated Genes by TNF-α and IFN-α Augments Antiviral Activity against HCV and HEV. |
| Q33839633 | Coordinate viral induction of tumor necrosis factor alpha and interferon beta in human B cells and monocytes |
| Q44354559 | Critical role of the C-terminus in the biological activities of human tumour necrosis factor-alpha. |
| Q37583568 | Cytokine determinants of viral tropism. |
| Q35533663 | Cytokine gene regulation: regulatory cis-elements and DNA binding factors involved in the interferon system |
| Q37395974 | Cytokine production by human leukocytes with different expressions of natural antiviral immunity and the effect of antibodies against interferons and TNF-alpha |
| Q36954574 | Cytokine regulation of human immunodeficiency virus expression |
| Q36494132 | Cytokines and Human Malignant Melanoma Immuno- and Growth-Regulatory Peptides in Melanoma Biology |
| Q33863961 | Cytokines and their receptors in cardiovascular diseases--role of gp130 signalling pathway in cardiac myocyte growth and maintenance |
| Q40896076 | Cytokines, sepsis and immunomodulation |
| Q35990527 | Death effector domain-containing herpesvirus and poxvirus proteins inhibit both Fas- and TNFR1-induced apoptosis |
| Q40741932 | Dengue haemorrhagic fever and dengue shock syndrome: are they tumour necrosis factor-mediated disorders? |
| Q41499470 | Determination of 2-5A synthetase and 2-5A phosphodiesterase in neuroblastoma cells by analytical capillary isotachophoresis: effects of cytokines and comparison with radioenzymatic methods |
| Q43752701 | Dietary supplementation with omega-3 polyunsaturated fatty acids from fish oil in chronic liver disease |
| Q43818266 | Differential regulation of lymphotoxin and tumor necrosis factor genes in human T lymphocytes |
| Q39577917 | Distinct pathways for tumor necrosis factor alpha and ceramides in human cytomegalovirus infection. |
| Q34326864 | Disturbance of tumor necrosis factor alpha-mediated beta interferon signaling in cervical carcinoma cells |
| Q74501893 | Echinacea-induced cytokine production by human macrophages |
| Q45833840 | Effect of culture supernatant of MT-2 cells on human immunodeficiency virus-producing cells, MOLT-4/HIVHTLV-IIIB cells |
| Q70489762 | Effect of lipoarabinomannan and mycobacteria on tumour necrosis factor production by different populations of murine macrophages |
| Q45265417 | Effect of morphine on lipopolysaccharide-induced tumor necrosis factor-alpha production in vivo: involvement of the sympathetic nervous system |
| Q43787075 | Effects of the Japanese herbal medicine 'Sho-saiko-to' as a cytokine inducer |
| Q44433473 | Effects of tumor necrosis factor alpha on replication of varicella-zoster virus |
| Q96606903 | Effects of tumor necrosis factor on viral replication and pulmonary inflammation during acute mouse adenovirus type 1 respiratory infection |
| Q40771367 | Elevated temperature regulates tumor necrosis factor-mediated immune killing |
| Q45788011 | Enhancement by TNF-? of reactivation and replication of latent herpes simplex virus from trigeminal ganglia of mice |
| Q45832900 | Enhancement of human immunodeficiency virus production by natural lymphotoxin |
| Q34553626 | Epstein-Barr virus immediate-early protein BZLF1 inhibits tumor necrosis factor alpha-induced signaling and apoptosis by downregulating tumor necrosis factor receptor 1 |
| Q36424417 | Epstein-Barr virus immunossuppression of innate immunity mediated by phagocytes |
| Q37764571 | Evaluation of TNF as antiviral, antibacterial and antiparasitic agent |
| Q42443957 | Evidence for a deficiency of interferon response in mononuclear cells from hepatitis C viremic patients |
| Q55342232 | Expression of membrane-associated lymphotoxin/tumor necrosis factor-beta on human lymphokine-activated killer cells. |
| Q38203806 | Expression of the genes of interferons and other cytokines in normal and diseased tissues of man. |
| Q59358622 | Fas activity mediates airway inflammation during mouse adenovirus type 1 respiratory infection |
| Q36636274 | Functional complementation of the adenovirus E1B 19-kilodalton protein with Bcl-2 in the inhibition of apoptosis in infected cells |
| Q40372624 | Functional organization of variola major and vaccinia virus genomes |
| Q38239127 | HBV Reactivation in Patients Treated with Antitumor Necrosis Factor-Alpha (TNF-α) Agents for Rheumatic and Dermatologic Conditions: A Systematic Review and Meta-Analysis. |
| Q37254436 | Hepatic expression of tumour necrosis factor-alpha in chronic hepatitis B virus infection |
| Q35613809 | Herpes simplex virus infection and apoptosis |
| Q35873842 | Herpes simplex virus type 2 inhibition of Fas ligand expression |
| Q41020010 | High levels of circulating soluble receptors for tumor necrosis factor in hairy cell leukemia and type B chronic lymphocytic leukemia |
| Q40100851 | Human gamma interferon and tumor necrosis factor exert a synergistic blockade on the replication of herpes simplex virus |
| Q43046781 | IL-1 beta and TNF-alpha produced by peripheral blood mononuclear cells before and during interferon therapy in patients with chronic hepatitis C. |
| Q34117997 | Immunomodulators in infectious diseases: panoply of possibilites |
| Q33895630 | Immunomodulatory agents for prophylaxis and therapy of infections |
| Q37181575 | Immunoregulators in the nervous system |
| Q69043503 | In vitro antiproliferative efficacy of interferon-alpha, -gamma and tumor necrosis factor on two human renal tumor xenografts |
| Q69039045 | In vivo and in vitro induction of natural killer cells by cloned human tumor necrosis factor |
| Q41896594 | Increased tumor necrosis factor-alpha (TNF-alpha) gene expression in parainfluenza type 1 (Sendai) virus-induced bronchiolar fibrosis |
| Q45863869 | Increased tumor necrosis factor-alpha receptor number in chronic hepatitis B virus infection |
| Q39592683 | Induction of necrotic-like cell death by tumor necrosis factor alpha and caspase inhibitors: novel mechanism for killing virus-infected cells |
| Q36782589 | Induction of sensitivity to the cytotoxic action of tumor necrosis factor alpha by adenovirus E1A is independent of transformation and transcriptional activation |
| Q35853222 | Induction of susceptibility to tumor necrosis factor by E1A is dependent on binding to either p300 or p105-Rb and induction of DNA synthesis |
| Q34325874 | Induction of the transcription factor IRF-1 and interferon-beta mRNAs by cytokines and activators of second-messenger pathways |
| Q40343714 | Infection of peripheral blood mononuclear cells by herpes simplex and Epstein-Barr viruses. Differential induction of interleukin 6 and tumor necrosis factor-alpha |
| Q35853529 | Inflammatory infiltration of the trigeminal ganglion after herpes simplex virus type 1 corneal infection |
| Q41500962 | Influenza A virus replication is inhibited by tumor necrosis factor-alpha in vitro |
| Q37899616 | Inhibition of Chlamydia trachomatis growth by recombinant tumor necrosis factor |
| Q37899339 | Inhibition of Chlamydia trachomatis replication in HEp-2 cells by human monocyte-derived macrophages |
| Q27489517 | Inhibition of Intrahepatic Gamma Interferon Production by Hepatitis C Virus Nonstructural Protein 5A in Transgenic Mice |
| Q36984332 | Inhibition of Rickettsia conorii growth by recombinant tumor necrosis factor alpha: enhancement of inhibition by gamma interferon |
| Q35105367 | Inhibition of growth of Chlamydia trachomatis by tumor necrosis factor is accompanied by increased prostaglandin synthesis |
| Q38337427 | Inhibition of tumor necrosis factor-α transcription by Epstein-Barr virus |
| Q52252114 | Inhibition of tumour necrosis factor and natural cytotoxic cell lytic activities by a spleen cell-elaborated factor |
| Q39909631 | Inhibitory Effect of TNF-alpha Produced by Macrophages Stimulated with Grifola frondosa Extract (ME) on the Growth of Influenza A/Aichi/2/68 Virus in MDCK Cells |
| Q45880144 | Interaction of interferon-α with interleukin-1β or tumor necrosis factor-α on hepatitis B virus enhancer activity |
| Q36353958 | Interferon beta 1, an intermediate in the tumor necrosis factor alpha-induced increased MHC class I expression and an autocrine regulator of the constitutive MHC class I expression |
| Q39665768 | Interleukin 1, tumour necrosis factor-alpha (cachectin) and the pathogenesis of cancer cachexia |
| Q36628106 | Interleukin-2 and alpha/beta interferon down-regulate hepatitis B virus gene expression in vivo by tumor necrosis factor-dependent and -independent pathways |
| Q45879841 | Lipopolysaccharide suppresses cytokine release from coxsackie virus-infected human monocytes |
| Q37506760 | Local production of tumor necrosis factor encoded by recombinant vaccinia virus is effective in controlling viral replication in vivo |
| Q41300846 | M-T2: a poxvirus TNF receptor homologue with dual activities. |
| Q41640832 | Macrophage priming and lipopolysaccharide-triggered release of tumor necrosis factor alpha during graft-versus-host disease |
| Q40324896 | Macrophage-mediated inhibitory effect of Zingiber officinale Rosc, a traditional oriental herbal medicine, on the growth of influenza A/Aichi/2/68 virus. |
| Q33205985 | Mechanisms in prostatitis/chronic pelvic pain syndrome |
| Q30392930 | Microbubble-mediated ultrasound promotes accumulation of bone marrow mesenchymal stem cell to the prostate for treating chronic bacterial prostatitis in rats |
| Q41300792 | Molecular basis of immune evasion strategies by adenoviruses |
| Q69698588 | Natural cytotoxic activity is not necessarily mediated by the release of tumour necrosis factor |
| Q34228539 | Overexpression of tumor necrosis factor alpha by a recombinant rabies virus attenuates replication in neurons and prevents lethal infection in mice |
| Q40779573 | Phase I study of recombinant human tumor necrosis factor alpha in advanced malignant disease |
| Q40754298 | Phase I trial of recombinant human tumour necrosis factor α in patients with advanced malignancy |
| Q72756384 | Pilot study of natural human interleukin-2 in patients with chronic hepatitis B. Immunomodulatory and antiviral effects |
| Q36577650 | Polyfunctional analysis of human t cell responses: importance in vaccine immunogenicity and natural infection |
| Q33677323 | Posttranscriptional clearance of hepatitis B virus RNA by cytotoxic T lymphocyte-activated hepatocytes |
| Q44003358 | Preactivation of macrophages in mice acutely infected with Schistosoma mansoni |
| Q72724320 | Production of an early release, M(r) 36,000 monokine by stimulated rat macrophages |
| Q36627744 | Production of lipopolysaccharide-induced tumour necrosis factor during influenza virus infection in mice coincides with viral replication and respiratory oxidative burst |
| Q40847654 | Production of porcine TNFα by ADAM17-mediated cleavage negatively regulates porcine reproductive and respiratory syndrome virus infection |
| Q45854429 | Production of tumor necrosis factor-alpha by blood and lung mononuclear phagocytes from patients with human immunodeficiency virus-related lung disease |
| Q35109154 | Production of tumor necrosis factors alpha and beta by human mononuclear leukocytes stimulated with mitogens, bacteria, and malarial parasites |
| Q41139213 | Purification of an atypical bovine interferon induced in response to heat shock in bovine cultured cells. Characterization in comparison with the classical alpha, beta and gamma interferon |
| Q40671154 | RNase L mediates transient control of the interferon response through modulation of the double-stranded RNA-dependent protein kinase PKR. |
| Q35077002 | Receptor-ligand requirements for increased NK cell polyfunctional potential in slow progressors infected with HIV-1 coexpressing KIR3DL1*h/*y and HLA-B*57 |
| Q36828251 | Regulation of the interferon-inducible IFI-78K gene, the human equivalent of the murine Mx gene, by interferons, double-stranded RNA, certain cytokines, and viruses |
| Q54684335 | Release of tumor necrosis factor-alpha from bovine alveolar macrophages stimulated with bovine respiratory viruses and bacterial endotoxins |
| Q41029868 | Replication of bovine respiratory syncytial virus in bovine and ovine peripheral blood lymphocytes and monocytes and monocytic cell lines |
| Q36548693 | Repression of retrovirus-mediated transgene expression by interferons: implications for gene therapy |
| Q39004337 | Reverse genetics of rabies virus: new strategies to attenuate virus virulence for vaccine development |
| Q37897635 | Reversion of the antichlamydial effect of tumor necrosis factor by tryptophan and antibodies to beta interferon. |
| Q30702806 | Robust expression of TNF-alpha, IL-1beta, RANTES, and IP-10 by human microglial cells during nonproductive infection with herpes simplex virus. |
| Q34557411 | Secretory products of macrophages |
| Q53850181 | Serum tumour necrosis factor alpha levels in benign and malignant lesions of the endometrium in postmenopausal women. A preliminary study. |
| Q44998870 | Stimulation of macrophages by endotoxin results in the reactivation of a persistent herpes simplex virus infection |
| Q35077813 | Strong human endogenous retrovirus-specific T cell responses are associated with control of HIV-1 in chronic infection |
| Q41792389 | Structure of tumour necrosis factor |
| Q46586795 | Subconjunctival antisense oligonucleotides targeting TNF-alpha influence immunopathology and viral replication in murine HSV-1 retinitis |
| Q45789818 | THF gamma 2 stimulates cytokine release by peripheral blood mononuclear cells of patients with chronic hepatitis B virus infection |
| Q36816831 | The 19-Kilodalton Adenovirus E1B Transforming Protein Inhibits Programmed Cell Death and Prevents Cytolysis by Tumor Necrosis Factor α |
| Q24563120 | The C-mer gene is induced by Epstein-Barr virus immediate-early protein BRLF1 |
| Q40064866 | The E1B 19,000-molecular-weight protein of group C adenoviruses prevents tumor necrosis factor cytolysis of human cells but not of mouse cells |
| Q34999197 | The ELISPOT assay: an easily transferable method for measuring cellular responses and identifying T cell epitopes |
| Q36658280 | The Impact of Macrophage- and Microglia-Secreted TNFα on Oncolytic HSV-1 Therapy in the Glioblastoma Tumor Microenvironment |
| Q35947867 | The RNA binding domain of influenza A virus NS1 protein affects secretion of tumor necrosis factor alpha, interleukin-6, and interferon in primary murine tracheal epithelial cells |
| Q36620321 | The adenovirus E3 14.7-kilodalton protein which inhibits cytolysis by tumor necrosis factor increases the virulence of vaccinia virus in a murine pneumonia model. |
| Q36681830 | The amino-terminal portion of CD1 of the adenovirus E1A proteins is required to induce susceptibility to tumor necrosis factor cytolysis in adenovirus-infected mouse cells |
| Q39204110 | The common mediator of shock, cachexia, and tumor necrosis. |
| Q36436880 | The molecular action of tumor necrosis factor-alpha |
| Q68498648 | The presence of cachectin/tumor necrosis factor in human disease states |
| Q39874089 | The role of human adenovirus early region 3 proteins (gp19K, 10.4K, 14.5K, and 14.7K) in a murine pneumonia model. |
| Q39572319 | The role of tumor necrosis factor and interleukin 1 in the immunoinflammatory response |
| Q73468006 | The roles of tumour necrosis factor-alpha, interleukin-1 and interleukin-12 in murine cytomegalovirus infection |
| Q36354711 | Three distinct classes of regulatory cytokines control endothelial cell MHC antigen expression. Interactions with immune gamma interferon differentiate the effects of tumor necrosis factor and lymphotoxin from those of leukocyte alpha and fibroblast |
| Q41103038 | To kill or to cure: options in host defense against viral infection. |
| Q39111105 | Transcriptional Regulation of Antiviral Interferon-Stimulated Genes |
| Q39510348 | Tumor necrosis factor (TNF) alpha: control of TNF-sensitivity and molecular mechanisms of TNF-mediated growth inhibition |
| Q39682351 | Tumor necrosis factor alpha exerts powerful anti-influenza virus effects in lung epithelial cells |
| Q41150293 | Tumor necrosis factor alpha induces the adenovirus early 3 promoter by activation of NF-kappaB. |
| Q35871524 | Tumor necrosis factor alpha inhibits entry of human immunodeficiency virus type 1 into primary human macrophages: a selective role for the 75-kilodalton receptor |
| Q40640525 | Tumor necrosis factor alpha levels in plasma and whole-blood culture in dengue-infected patients: relationship between virus detection and pre-existing specific antibodies |
| Q44476688 | Tumor necrosis factor alpha production by peripheral blood mononuclear cells of patients with chronic liver disease |
| Q37341883 | Tumor necrosis factor alpha stimulates expression of adenovirus early region 3 proteins: implications for viral persistence |
| Q34354649 | Tumor necrosis factor amplifies measles virus-mediated Ia induction on astrocytes |
| Q69026047 | Tumor necrosis factor induces expression of MHC class I antigens on mouse astrocytes |
| Q36357123 | Tumor necrosis factor plays a protective role in experimental murine cutaneous leishmaniasis |
| Q34333796 | Tumor necrosis factor type alpha, a potent inhibitor of endothelial cell growth in vitro, is angiogenic in vivo |
| Q37965274 | Tumor necrosis factor: an update on basic research and clinical applications |
| Q68774951 | Tumour necrosis factor (TNF alpha) in leishmaniasis. I. TNF alpha mediates host protection against cutaneous leishmaniasis |
| Q40644530 | Tumour necrosis factor and associated cytokines in the host's response to malaria |
| Q36029538 | Tumour necrosis factor in man: clinical and biological observations |
| Q28329734 | Tumour necrosis factor production in fulminant hepatic failure: relation to aetiology and superimposed microbial infection |
| Q42087829 | Tumour necrosis factor, cholestatic jaundice, and chronic liver disease |
| Q43906932 | Tumour necrosis factor-alpha and leukotriene E4 production in wheezy infants |
| Q37916679 | Tumour necrosis factor: a cytokine with multiple biological activities |
| Q37696074 | Type I interferon: a new player in TNF signaling |
| Q24292403 | Vaccinia virus CrmE encodes a soluble and cell surface tumor necrosis factor receptor that contributes to virus virulence |
| Q45851015 | Virus-vs endotoxin-induced activation of liver macrophages |
| Q71665497 | Was exposure to directly antiviral cytokines during primary infection an important selective pressure in the evolution of unique immune evasion strategies by viruses? |
Search more.